The efficacies of affected-limb care with penicillin, diethylcarbamazine, the combination of both drugs or antibiotic ointment, in the prevention of acute adenolymphangitis during bancroftian filariasis

Annals of Tropical Medicine and Parasitology

Volumn 98, Issue 7, 2004, Pages 685-696

  Joseph, A ^a   Mony, P ^a   Prasad, M ^a   John, S ^a   Srikanth, ^a   Mathai, D ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; DIETHYLCARBAMAZINE; FRAMYCETIN; PENICILLIN G; PLACEBO; ZINC OXIDE;

ADENOLYMPHANGITIS; ADULT; ANTIBODY TITER; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; EPIGASTRIC BURNING; EPIGASTRIC PAIN; FEMALE; FEVER; FILARIASIS; HEADACHE; HUMAN; INCIDENCE; INDIA; INFECTION CONTROL; LIMB; LYMPHANGITIS; LYMPHEDEMA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NAUSEA; PATIENT CARE; PATIENT EDUCATION; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SELF CARE; STREPTOCOCCUS; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; COMBINED MODALITY THERAPY; DIETHYLCARBAMAZINE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ELEPHANTIASIS, FILARIAL; EXTREMITIES; FEMALE; FILARICIDES; HUMANS; LYMPHANGITIS; MALE; MIDDLE AGED; OINTMENTS; PENICILLINS; SELF CARE; SEVERITY OF ILLNESS INDEX;

BACTERIA (MICROORGANISMS); NEMATODA; STREPTOCOCCUS;

EID: 6344227863     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1179/000349804225021451     Document Type: Article

References (28)

1. Addiss, D. G., Eberhard, M. L. & Lammie, P. J. (1994). 'Filarial' adenolymphangitis without filarial infection. Lancet, 343, 597.
2. Anon. (1993). Recommendations of the International Task Force for Disease Eradication. Morbidity and Mortality Weekly Report, 42, 1-38.
3. Anon. (1996). Project Area Report, 1996. Vellore, India: Department of Community Health, Christian Medical College and Hospital.
4. Anon. (2001). Myers and Koshi's Manual of Diagnostic Procedures in Medical Microbiology and Immunology/serology. Pondicherry, India: All India Press
5. Dreyer, G., Noroes, J. & Addiss, D. (1997). The silent burden of sexual disability associated with lymphatic filariasis. Acta Tropica, 63, 57-60.
6. Evans, D. B., Gelband, H. & Vlassoff, C. (1993). Social and economic factors and the control of lymphatic filariasis: a review. Acta Tropica, 53, 1-26.
7. Ewert, A., Reitmeyer, J. C. & Folse, D. (1980). Chronic infection of cats with Brugia malayi and Streptococcus. Southeast Asian Journal of Tropical Medicine and Public Health, 11, 32-39.
8. Meinert, C. L. (1988). Clinical Trials: Design, Conduct, and Analysis. New York: Oxford University Press
9. Michael, E., Bundy, D. A. & Grenfell, B. T. (1996). Re-assessing the global prevalence and distribution of lymphatic filariasis. Parasitology, 112, 409-428.
10. Olszewski, W. & Jamal, S. (1994). Skin bacterial factor in progression of filarial lymphoedema. Lymphology, 27, 148-149.
11. Olszewski, W. L., Jamal, S., Manokaran, G., Lukomska, B. & Kubicka, U. (1993). Skin changes in filarial and non-filarial lymphoedema of the lower extremities. Tropical Medicine and Parasitology, 44, 40-44.
12. Olszewski, W.L., Jamal, S., Manokaran, G., Pani, S., Kumaraswami, V., Kubicka, U., Lukomska, B., Dworczynski, A., Swoboda, E. & Meisel-Mikolajczyk, F. (1997). Bacteriologic studies of skin, tissue fluid, lymph, and lymph nodes in patients with filarial lymphoedema. American Journal of Tropical Medical and Hygiene, 57, 7-15.
13. Ottesen, E. A. (1980). Immunopathology of lymphatic filariasis in man. Springer Seminars in Immunopathology, 2, 373-385.
14. Ottesen, E. A. (1985). Efficacy of diethylcarbamazine in eradicating infection with lymphatic-dwelling filariae in humans. Review of Infectious Diseases, 7, 341-356.
15. Ottesen, E. A. (1993). Filarial infections. Infectious Disease Clinics of North America, 7, 619-633.
16. Ottesen, E. A., Duke, B. O., Karam, M. & Behbehani, K. (1997). Strategies and tools for the control/elimination of lymphatic filariasis. Bulletin of the World Health Organization, 75, 491-503.
17. Pani, S. P., Yuvaraj, J., Vanamail, P., Dhanda, V., Michael, E., Grenfell, B. T. & Bundy, D. A. (1995). Episodic adenolymphangitis and lymphoedema in patients with bancroftian filariasis. Transactions of the Royal Society of Tropical Medicine and Hygiene, 89, 72-74.
18. Partono, F. (1987). The spectrum of disease in lymphatic filariasis. Ciba Foundation Symposium, 127, 15-31.
19. Ramaiah, K. D., Ramu, K., Guyatt, H., Kumar, K. N. & Pani, S. P. (1998). Direct and indirect costs of the acute form of lymphatic filariasis to households in rural areas of TamilNadu, south India. Tropical Medicine and International Health, 3, 108-115.
20. Ramaiah, K. D., Radhamani, M. P., John, K. R., Evans, D. B., Guyatt, H., Joseph, A., Datta, M. & Vanamail, P. (2000). The impact of lymphatic filariasis on labour inputs in southern India: results of a multi-site study. Annals of Tropical Medicine and Parasitology, 94, 353-364.
21. Schulz, K. F. & Grimes, D. A. (2002). Allocation concealment in randomized trials: defending against deciphering. Lancet, 359, 614-618.
22. Shenoy, R. K., Suma, T. K., Rajan, K. & Kumaraswami, V. (1998). Prevention of acute adenolymphangitis in brugian filariasis: comparison of the efficacy of ivermectin and diethylcarbamazine, each combined with local treatment of the affected limb. Annals of Tropical Medicine and Parasitology, 92, 587-594.
23. Shenoy, R. K., Kumaraswami, V., Suma, T. K., Rajan, K. & Radhakuttyamma, G. (1999). A double-blind, placebo-controlled study of the efficacy of oral penicillin, diethylcarbamazine or local treatment of the affected limb in preventing acute adenolymphangitis in lymphoedema caused by brugian filariasis. Annals of Tropical Medicine and Parasitology, 93, 367-377.
24. Suma, T. K., Shenoy, R. K., Varghese, J., Kuttikkal, V. V. & Kumaraswami, V. (1997). Estimation of ASO titer as an indicator of streptococcal infection precipitating acute adenolymphangitis in brugian lymphatic filariasis. Southeast Asian Journal of Tropical Medicine and Public Health, 28, 826-830.
25. World Health Organization (1991). Lymphatic Filariasis: Disease and its Control. Fifth Report of the WHO Expert Committee on Filariasis. Technical Report Series No. 821. Geneva: WHO.
26. World Health Organization (1992). Informal Consultation on Evaluation of Morbidity in Lymphatic Filariasis, Tuberculosis Research Centre, Madras, 10-11 February 1992. Document WHO/TDR/FIL/92.3. Geneva: WHO.
27. World Health Organization (1994). Lymphatic Filariasis. Infection and Disease: Control Strategies. Document TDR/CTD/FIL/PENANG/94.1. Geneva: WHO.
28. World Health Organization (1995). The World Health Report: Bridging the Gap. Geneva: WHO.